Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse

Documenti analoghi

• Ex Vivo and in Vivo Effects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
  di: Sun, Ying, et al.
  Pubblicazione: (2012)
• Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice
  di: Xu, You-hai, et al.
  Pubblicazione: (2014)
• Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice
  di: Liou, Benjamin, et al.
  Pubblicazione: (2016)
• Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits
  di: Sun, Ying, et al.
  Pubblicazione: (2010)
• In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid β-Glucosidase in Gaucher Disease Mouse Models
  di: Sun, Ying, et al.
  Pubblicazione: (2009)